Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-04-2024 | ECMO | Case report

Epoprostenol

Refractory bronchospasm and off-label use

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Hammond TC, et al. Refractory Bronchospasm Due to Inhaled Veletri in a Patient With Acute COVID-19 Associated Respiratory Failure. American Journal of Respiratory and Critical Care Medicine 207: May 2023. Available from: URL: https://dx.doi.org/10.1164/ajrccm-conference.2023.B55 [abstract] Hammond TC, et al. Refractory Bronchospasm Due to Inhaled Veletri in a Patient With Acute COVID-19 Associated Respiratory Failure. American Journal of Respiratory and Critical Care Medicine 207: May 2023. Available from: URL: https://​dx.​doi.​org/​10.​1164/​ajrccm-conference.​2023.​B55 [abstract]
Metadata
Title
Epoprostenol
Refractory bronchospasm and off-label use
Publication date
01-04-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56836-2

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Antineoplastics

Case report

Heparin

Case report

Antineoplastics

Case report

BCG

Case report

Lithium